Author

E. Çubukçu

View on Semantic Scholar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Evaluation of Olaparib Efficacy Following CDK4/6 Inhibitor Therapy in BRCA-Mutated, Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Turkish Oncology Group (TOG) Study.

Z. Gökdere, T. Şahin, I. Bilgetekin et al. · Targeted oncology · 0 citations

Review Open access Oct 2026

Is 18 F-FDG PET/CT Necessary During Vismodegib Therapy for Basal Cell Carcinoma? Quantitative Changes and Incremental Value Beyond CT

Abstract Objectives The role of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) in monitoring basal cell carcinoma (BCC) during vismodegib therapy remains poorly defined, particularly in patients with extensive, multifocal, or Gorlin syndrome–associated disease. This study ai...

S. Bilgiç, Çağla Karaoğlu, Elif İşleyen Çolak et al. · World Journal of Nuclear Med... · 0 citations